All Publications from Accelerate Diagnostics

Over the past several years, Accelerate Diagnostics and our scientific collaborators have conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.

These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures.

Certain uses of devices included in these publications may not have been approved or cleared by the U.S. Food and Drug Administration or other regulatory bodies.

See product labeling for instructions for use, warnings, and limitations specific to each product and region.

Okay, I understand. Show me the publications.


Filter by:
Jun 24, 2019

Identification of difficult to detect MRSA/MSSA strains by two commercial AST methods
ASM Microbe 2019
J Towne, R Humphries (Accelerate Diagnostics)

Jun 24, 2019

Reduced Time to Results for a Phenotypic MRSA Detection Assay for Use Directly from Positive Blood Cultures
ASM Microbe 2019
Dulini Gamage, Niels Oppermann, Alena Shamsheyeva, Christina Chantell, Kyle Spafford (Accelerate Diagnostics)

Jun 24, 2019

In silico evaluation of ceftriaxone susceptibility prediction among Enterobacteriaceae by two rapid blood culture diagnostic tests
ASM Microbe 2019
Kyle Spafford, Shawn MacVane, Romney Humphries (Accelerate Diagnostics)

Jun 24, 2019

Two Rapid Phenotypic Antimicrobial Susceptibility Tests for Gram-Negative Rod Bacteremia
ASM Microbe 2019
Cassiana E. Bittencourt, Brenda Herrera, Hiroki Saito, Sara Sirajuddin, Wint Thu Hun, Steven Park, Ellena Peterson, Lauri Thrupp ( University of California Irvine)

Jun 24, 2019

Evaluation of Rapid Antimicrobial Susceptibility Testing Methods for Gram-Negative Isolates
ASM Microbe 2019
Bhalodi A, Miquirray S, Perez I, Towne J, Humphries R (Accelerate Diagnostics)

Jun 24, 2019

One Step Closer to Enterobacteriaceae ID/AST Direct from Blood: Evaluating Pre-Process Incubation Times
ASM Microbe 2019
S. Giddins, I. Yushkevich, M. Fuchs, A. Irwin, S. Metzger, C. Price (Denver Health and Hospital Authority; Accelerate Diagnostics, Inc)

Jun 24, 2019

Improving Outcomes and Antibiotic Stewardship for Patients with Bacteremia (IOAS): An Interim Analysis of Gram-Negative Bacteremia (GNB) from the Accelerate PhenoTest™ BC Kit (AXDX) Registry Study
ASM Microbe 2019
S. H. MacVane, M. A. Ben-Aderet, J. Kolev, M. Madhusudhan, R. K. Dare, K. Lusardi, E. Rosenbaum, M. A. Morgan, R. M. Humphries (Accelerate Diagnostics, Inc., Cedars-Sinai Medical Center, University of Arkansas for Medical Sciences)

May 29, 2019

Making the Business Case for a Fast Diagnositic Platform for BSIs with a Clinical Implementation Support Team
IPAC 2019
Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC; Jared Sutton, MPH, CIC; Nicholas Strohminger, et al. (Accelerate Diagnostics, Inc.)

May 16, 2019

Clinical impact of rapid species identification from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections
Clinical Infectious Diseases
Ehren K, Meißner A, Jazmati N, et al. (University Hospital of Cologne)

May 01, 2019

A Pilot Study of Accelerate PhenoTest™ BC kit (AXDX) Compared to Standard Microbiological Testing on Blood Cultures Positive for Gram negative Bacilli
AMMI 2019
William Stokes MD, Lorraine Campbell, Johann Pitout MD, John Conly MD, Deirdre Church MD, Dan Gregson MD (University of Calgary, Calgary Laboratory Services)